AKAP9
(A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-AKAP9 antibody (Catalog #: ARP38677_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
AKAP9
(A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))
Hintergrund
The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. AKAP9 is a member of the AKAP family. Alternate splicing of this gene results in many isoforms that localize to the centrosome and the Golgi apparatus, and interact with numerous signaling proteins from multiple signal transduction pathways.
Protein Interaction Partner: CALM3,CEP55,CLIC1,CSNK1D,CSNK1E,FNBP1,GRIN1,KCNQ1,PCNT,PKN1,PPP1CA,PPP2R1B,PPP2R3A,PRKAR2A,PRKAR2B,PRKCE,TACC3,TRIP10,TSNAX,TUBGCP3,CALM1,CALM2,CLIC1,CSNK1D,CSNK1E,Csnk1d,Csnk1e,FNBP1,KCNQ1,PKN1,PMS1,PRKAR2A,TACC3,TRIP10,TUBGCP3